The purpose of this multicenter randomly controlled clinical trial was to compare 2 acellular dermal matrix (ADM) materials produced by different processing techniques, freeze-dried (FDADM) and solventdehydrated ADM (SDADM), in their ability to correct Miller's Class I and II recession defects.
autograft has been the gold standard for treating recession; however, the morbidity associated with harvesting donor tissue from a second surgical site has led clinicians to seek other, less invasive alternatives. To meet this challenge, ADM was developed and has shown promising results. 4, [6] [7] [8] [9] Two major types of acellular dermal matrix (ADM) products are commercially available; one is freeze-dried (FDADM) ∏ and the other is prepared by solvent dehydration (SDADM). ¶ In both processes, epidermis and the cellular elements of dermis are removed to provide a material consisting primarily of fibrillar collagen mesh and elastin. According to the manufacturer, processing of FDADM begins with removal of the epidermis using a buffered salt solution. Multiple cell types within the dermis are then dissolved and washed away using a nondenaturing detergent that rapidly diffuses into the dermis. Finally, after a cryopreservant is added to avoid damaging crystal formations, the processed tissue matrix is freeze-dried. For SDADM, according to the manufacturer, the Tutoplast ® process was used to gently remove unwanted materials such as cells, antigens and viruses, and inactivate any pathogens. 10 The steps in processing include osmotic, oxidative and alkaline treatment, solvent dehydration and limiteddose gamma irradiation for sterilization. During solvent dehydration, the tissue is placed several times in different gradations of acetone. At the end of this step, acetone is left to evaporate in a vacuum chamber. This results in dry tissue with residual water content of less than 5% that can be stored at room temperature. When used as a graft, ADM acts as a scaffold for new tissue growth. Although ADM has been used successfully to treat recession defects, there has been only one direct comparison of FDADM and SDADM for treatment of human gingival recession defects reported in the literature. 11 The purpose of this study was to evaluate whether clinical parameters were improved by solvent-dehydrated ADM (SDADM) when compared to freeze-dried ADM (FDADM) for the treatment of Miller's Class I or II gingival recession 12 defects in a multicenter randomized controlled clinical trial.
MATERIALS AND METHODS
The study population consisted of patients with one Miller's Class I or II facial gingival recession defect, greater than or equal to 2mm, located on the facial aspect of a maxillary incisor, canine or premolar from 4 centers (Center 3515:University of Michigan School of Dentistry, Center 3507:Eastman Institute for Oral Health, University of Rochester, NY, Center 3514:University of Alabama at Birmingham School of Dentistry and Rutgers, Center 3508: Rutgers, The State University of New Jersey). The Western Institutional Review Board (IRB) and each center IRB approved this project, and the study was conducted in accordance with the Helsinki Declaration of 1975 as revised in 2000. All subjects gave written and verbal consent to participate. A power analysis was conducted to determine the sample size based on testing the difference of gingival recession reduction from baseline to 1 year between FDADM treatment and SDADM treatment. Assuming there is no root coverage status changes from 6 months to 1 year after surgery, according to Novaes et al. (2001) 13 , it was estimated the two treatment groups have common standard deviation of 1mm. The two groups' sample size ratio was set as 1:1. It was determined that a sample size of 34 per group would provide 80% power to detect 0.7mm difference between the group means at type I error rate of 0.05 using a two-sided Student's T test. Based on the power size calculation, from November 2009 to December 2010, a total of 80 subjects, 54 (67.5%) females and 26 (32.5%) males, were enrolled in this prospective randomized controlled trial in 4 study centers. This multicenter randomized clinical trial is registered at U.S. National Institutes of Health Clinical Trials Registry with the number NCT00881959.
Subjects were ≥ 18 years of age, able to understand and comply with all instructions and able to maintain good oral hygiene (O'Leary Plaque Score ≤20%) 14 . Exclusion criteria included prior surgery in the study area within the past 12 months, antibiotic use exceeding 2 weeks duration within the past 3 months, allergy to any of the study materials, concomitant use of medications known to cause gingival enlargement, use of systemic steroids, unstable systemic diseases, compromised immune function, active infection, and tobacco use within the past year. In addition, females who were pregnant or attempting to become pregnant were excluded.
Subjects were assigned randomly to one of two treatment groups on the day of surgery: CAF+SDADM or CAF+FDADM. A third party (sponsor) # provided a box containing 20 sequential randomization cards for each center in sealed envelopes. FDADM group included 42 subjects and SDADM included 38 subjects, the non-significant difference being attributed to randomization. All centers had enrolled 20 patients and they are equally divided in each group 10 patients each except center 3508 which had 8 patients in SDADM and 12 patients in FDADM. FDADM had 26 (61.9%) females and 16 (38.1%) males, while SDADM had 28 (73.7%) females and 10 (26.3%) males. Immediately prior to surgery, the surgeon drew an envelope from the box and opened it to reveal the treatment group for the subject. Randomization was performed prior to surgery because the rehydration process for the test and control ADM materials had to be initiated before the surgical procedure started. Rehydration of ADM materials was performed according to manufacturers' instructions. SDADM was hydrated for 5-30 minutes in endotoxinfree, room temperature 0.9% sterile saline. FDADM was hydrated in two separate saline baths, 10 minutes each, for a total of 20 minutes.
All surgeries were performed as previously described 15 using CAF, periosteal release and blunt dissection for tension-free closure, and the sling-and-tag suturing technique. Surgeons (HLW, GR, AS, NG, RE) from each center measured recession depth (X) with a University of North Caroline (UNC)-15 periodontal probe χ and then used the same probe to create a bleeding point apical to each adjacent gingival papilla at a distance equal to the recession depth plus 1mm (X + 1). Starting at the level of the bleeding points, diverging vertical incisions were made at mesiofacial and distofacial line angles of the study tooth. After connecting the vertical incisions with a sulcular incision, a full-thickness mucoperiosteal flap was elevated several millimeters beyond the mucogingival junction. An Orban interproximal knife or 12B scalpel was then used to de-epithelialize adjacent gingival papillae. The exposed root was planed with curettes and any tissue tags were removed from the flap and adjacent papillae with curved iris scissors. Next, the periosteum was scored near the base of the flap and submucosal tissues were undermined via blunt dissection with a pair of scissors to allow coronal positioning of the flap without tension, in the following fashion: while grasping the flap with tissue forceps and applying gentle traction in a coronal and lateral direction, the surgeon made a shallow horizontal incision through the periosteum on the internal aspect of the flap, at a level several millimeters apical to the vestibule. Curved Metzenbaum scissors ‡ were inserted, with the tips closed, into the incision in an apicolateral direction, paralleling and undermining the vestibular fold, and then were opened gently to bluntly separate the submucosal connective tissues and muscle fibers. This procedure was repeated until the flap could be pulled coronally without tension to a level that, in most cases, approximated the incisal edge or facial cusp tip of the tooth. The surgeon then trimmed the rehydrated ADM (SDADM or FDADM, depending on randomization) so that it was trapezoidal in shape, extended at least 3mm lateral and apical to the exposed root surface when positioned at the CEJ, and came no closer than 1mm to the vertical incisions outlining the recipient bed. The ADM graft was secured to the test tooth at the level of the CEJ with a single sling 5-0 fast absorbing-polyglycolic acid suture. χ The tissue flap was then advanced to a level 1-2mm coronal to the CEJ so the ADM was completely covered, and the flap was secured with the sling and tag suture technique with 5-0 polyglycolic acid sutures as previously described. 15 At the time of surgery, each surgeon completed a questionnaire regarding the handling characteristics of the ADM grafting material used. Postoperative medications included 600mg ibuprofen q6-8h as needed and amoxicillin 500mg t.i.d. for 10 days, starting 1 hour prior to surgery. Subjects were given azithromycin 500mg one hour prior to surgery and then 250mg per day for 5 days if they were allergic to amoxicillin. After surgery, subjects were instructed to rinse with warm salt water twice daily, not to brush or floss the area until after the 14 day postoperative visit or until the surgeon instructed them to do so, restrict physical activity for one week and to eat a soft diet. Postoperative visits were scheduled at 14 ± 3 days, 30 ± 7 days, 90 ± 7 days, 180 ± 14 days, and 365 ± 14 days. At the 14-day visit, the surgeon removed some or all external sutures as he/she deemed appropriate. At each postoperative visit, oral hygiene instructions and professional cleaning were provided if plaque accumulation was noted at the study site. Custom acrylic guides were fabricated to align probing depth, gingival recession and gingival thickness measurements at the midfacial aspect of the test teeth. Plaque Index (PlI) 16 , and Gingival Index (GI) 17 were recorded prior to surgery and at each postoperative visit. Wound Healing Index (WHI) 18 and patient discomfort level (1 = mild, 2 = mild to moderate, 3 = moderate, 4= moderate to severe, 5= severe) were recorded at each postoperative visit. Recession depth (RD) and recession width (RW) were recorded prior to surgery, after suturing and at each postoperative visit. Percentage of root coverage was a mathematical calculation taken directly from the midfacial measurement pre-treatment versus post-treatment. Probing depth (PD), clinical attachment level (CAL, equal to PD + RD) and gingival thickness (GT) were measured at baseline (prior to surgery) and at the 90, 180 and 365 day visits. After applying a topical anesthetic, GT was measured midfacially, 1mm and 3mm apical to the gingival margin, by penetrating the soft tissue with an endodontic broach that had an attached rubber stopper. GT measurements were then calculated to the nearest 0.5mm using a metal ruler. All other clinical measurements were made using a calibrated UNC-15 periodontal probe. ** To assess patient satisfaction, subjects filled out a patient quality assessment (PQA) form at the 180 day and 365 day visits.
Statistical Analysis
Demographic information, baseline information, and outcome clinical parameters follow-up assessments were summarized by the descriptive statistics chosen appropriate to the data scale.
Continuous data were summarized by mean, standard deviation, sample size (N), minimum and maximum. Categorical data were summarized by frequency and percentage. Student's T test was used to compare the primary clinical outcome parameters between FDADM treatment and SDADM treatment. Paired T test was used to evaluate the primary clinical outcome parameters improvement from baseline to 1 year within each treatment group. Kruskal-Wallis one-way analysis of variance was applied to examine the primary clinical outcome parameters' variations caused by the different clinical centers. Post-hoc pair-wise comparisons with p values adjusted for family-error rate were provided to identify the particular significant difference between the different centers.
RESULTS
Mean age was 47.4 ± 14.0 and 43.0 ± 13.0 years for FDADM and SDADM, respectively. There was no statistically significant difference in the distribution of Miller's class defects between groups, the majority being Miller class I. In addition, approximately half of the teeth treated in each group were maxillary canines. Most of the patients in both groups showed good to excellent oral hygiene throughout the study. Table 1 presents enrolled subjects' demographic information and defect characteristics. Figures 1 and 2 illustrate the patient treated with each processed membrane.
With regard to adverse events, only minimal complications were reported during the study period. Only 1 patient in each group reported graft exposure and infection. Interestingly, one patient in the SDADM group reported paresthesia after surgery; however, it was resolved during the follow-up period.
When evaluating the clinical parameters after one year, significant differences were found within groups for most of the parameters evaluated (Table 2 ). Both groups had significant (P<0.05) recession depth reduction (2.00±0.87mm for FDADM and 2.06±1.11mm for SDADM) and percentage of root coverage (77.20% ± 29.10% and 71.012 ± 32.87% for FDADM and SDADM, respectively; p=<0.0001)) when compared to baseline. Both groups showed a significant increase in attachment level (p<0.0001), being -1.69mm ± 1.07mm and -1.57mm ± 1.19mm for FDADM and SDADM, respectively.
On the other hand, no significant differences were observed between two treatment groups except for probing depths on the mesial side of the defects (p=0.03), being 2.63 ± 0.63 mm and 2.33 ± 0.57 mm for FDADM and SDADM, respectively. Although statistically significant, the clinical significance of this 0.3mm difference could be questioned. There were no significant differences between groups for attachment level, gingival thickness, probing depths, recession depth, recession width, and width of keratinized gingiva. Table 3 shows results of the surgeons' questionnaire regarding handling characteristics of the two test materials. There were no statistically significant differences between groups for any parameters except ease-of-handling, where SDADM scored higher than FDADM, at 97.4% and 73.8%, respectively.
When center effect was examined (supplement table 1), all 4 centers achieved similar clinical outcomes between both groups with two exceptions. Center 3507 achieved significantly greater mesial probing pocket depth reduction compared to Center 3514, and center 3508 achieved significantly increased gingival thickness compared to center 3514.
DISCUSSION
To date, there has been limited published information related to the influence of ADM manufacturing processes on clinical outcomes. 11 Results from our study found that there were no differences in clinical outcomes between solvent-dehydrated ADM (SDADM) and freeze-dried ADM (FDADM) for root coverage of Miller class I or II gingival recession defects. Both processed ADM materials achieved significant reduction of recession depth (average around 2mm) and gained more than 70% root coverage. This is in agreement with a previously published report where both ADMs were compared in a 6-month study although Miller's class III recession defects were also included in this study. 11 In that study, mean recession/percentage coverage were 2.83mm/81.4% and 3.13mm/83.4% root coverage in SDADM and FDADM, respectively. 11 Findings from above clearly indicated that the outcomes of root coverage in Miller's class I or II recession defects were not related to ADM processing techniques. In addition, the slightly lower percentage of root coverage achieved in our study might be due to our surgical approach, we employed the open approach which might jeopardize the blood supply and cause another surgical trauma that may induce tissue shrinkage during healing when compared to the tunnel approach. Currently, there is no study comparing the effect of the ADM processing under the tunnel surgical approach. Future research in this area is encouraged. Other factors that may influence current surgical approach outcomes have been addressed in several recent systematic reviews. [19] [20] [21] These include but are not limited to: failed to identify cementoenamel junction prior to surgery, different adjacent papillae dimension, different degree of root prominence, full thickness instead of partial thickness approach, flap stability, flap mobility, suturing…etc. When the surgeon failed to control these factors, poor clinical outcomes are often anticipated. [19] [20] [21] Data from our study showed both treatments improved CAL (1.7mm for FDADM and 1.6mm for SDADM), increased tissue thickness at 1mm and 3mm apical to the FGM (ranged from 0.3-1.0mm) and augmented keratinized tissue width (0.6 to 0.7mm). These results corroborate previous ADM studies 15, [22] [23] [24] that showed ADM achieved predictable root coverage and increased gingival thickness. Interestingly, a recent systematic review concluded that studies adding ADM under CAF demonstrated a great heterogeneity and no significant benefits compared to CAF alone. 21 However, they suggested that more studies with longer follow-up are needed to further evaluate the usage of this material under CAF.
It is likely that both ADM materials yielded comparable surgical results because both have a similar collagen matrix structure, which allows easy penetration of new vascular systems into open channels and integration into existing host tissue 25 . In addition Cummings et al 26 , in a human histologic study, showed grafted ADM formed an attachment directly to the root surface through a combination of connective tissue adhesion and long junctional epithelium which, in turn, increased the tissue thickness.
Our study also found that both KT and PD remained stable over the 12-month period, and that ADM slightly increased the zone of KT, which is in agreement with findings reported by Woodyard et al. 27 The fact that root coverage occurred without PD depth change over time implied that a new attachment, such as long junctional epithelium and connective tissue attachment, might have been established. It is important to note that the mesial and distal PD were recorded without custom surgical guide and this might cause some inconsistent recordings. Nonetheless, our findings also agree with a recent clinical study by Barker et al. 11 that found no difference in root coverage when using SDADM versus FDADM. Both findings are supported by the histologic report that showed that both SDADM and FDADM processed materials retained more natural architecture and physical properties than other material † † . 28 Hence, it may imply the long-term stability of ADM treatment.
In this study, minimal complications were noted in both materials, which imply ADM, regardless of processing, is a safe material to use in patients. This finding is supported by many previous reports. 3-8. In this study, the most common reported complications were graft exposure and graft infection, with only one case in each treatment group. In the SDADM group the complication was successfully treated with antibiotics and antimicrobial mouthrinse. In the FDADM group, surgical debridement and revision, antibiotics and mouthrinse were used to successfully treat the graft exposure and infection. Healing with ADM begins with preserved proteoglycans and proteins directing the patient's own cells to initiate revascularization and cell repopulation. Significant revascularization is observed after 7 to 10 days as fibroblasts begin tissue remodeling 29 . At 45 days, connective tissue forms through host collagen deposition and the ADM is repopulated with cells and remodels over the next 3 to 6 months 29 . If the ADM is left exposed, as in the case of free gingival grafting, the ADM matrix will support epithelial cell migration 28 . Although the complication incidence was low, it is important to recognize these possible complications and learn how to deal with them properly. In addition, both materials handle almost identical except SDADM showed better easy-handling characteristics than FDADM. This might be because the SDADM processing preserves the original dermis structure and by using chemical agents to dehydrate the material it eliminates the need for preserving the material in antibiotic solution under freeze-dried conditions. As a result, no dual hydration/dilution is needed prior to the clinical usage. As the result, no de-frozen is needed prior to the clinical usage. This is somehow supported by the study published by Hinton et al, who demonstrated that SDADM processed fascia lata works better as a grafting material than FDADM obtained from tissue banks. 30 Nonetheless, it has to be cautioned that fascia lata is not the same material as dermis although the same material processing techniques were used.
Interestingly, results from this study showed there was no difference among 4 centers. This suggested that, by adhering to the surgical protocol, clinical outcomes were predictable, no matter whom the operator. Nonetheless, to ensure the proper surgical technique was employed among centers, pre-study training was conducted to ensure similar surgical approaches were performed. This might explain why there was no center effect.
CONCLUSION
Within the limitation of this study, both freeze-dried and solvent-dehydrated ADM can be successfully used to correct Miller's class I or II recession defects with equivalent outcomes. There were no statistically significant differences between groups for any of the clinical parameters tested. 
